Inactive Instrument
GW Pharmaceuticals plc Stock London S.E.
Stocks
GB0030544687
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - GBX | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Alkesh Patel
SEC | Corporate Secretary | - | 2024-04-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Amanda Flanagan
BRD | Director/Board Member | 55 | 2025-02-09 |
David Spackman
BRD | Director/Board Member | 50 | 2023-01-12 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.53% | +0.78% | +72.33% | +127.47% | 57.72B | ||
| -2.45% | -7.32% | +65.23% | +83.15% | 52.65B | ||
| +3.06% | +8.77% | +21.05% | +470.49% | 24.46B | ||
| -1.61% | -1.00% | -16.73% | -13.45% | 23.84B | ||
| -3.05% | +3.06% | +42.36% | -5.66% | 19.28B | ||
| -0.24% | +5.11% | +38.76% | -25.95% | 17.8B | ||
| +2.34% | +14.18% | +220.96% | +380.99% | 17.29B | ||
| -6.73% | +9.90% | +36.04% | - | 15.28B | ||
| -2.25% | +3.60% | +28.49% | +193.16% | 14.35B | ||
| Average | -1.33% | +5.20% | +56.50% | +151.27% | 26.96B | |
| Weighted average by Cap. | -1.35% | +2.71% | +57.74% | +139.44% |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















